Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,631 | 22,435 | 24,878 | 11,284 | 14,758 |
| Receivables | 4,141 | 2,448 | 4,240 | 3,298 | 4,263 |
| Inventories | 2,586 | 2,767 | 3,030 | 3,089 | 2,533 |
| TOTAL | $28,856 | $27,868 | $32,819 | $18,680 | $22,651 |
| Non-Current Assets | |||||
| PPE Net | 519 | 565 | 591 | 638 | 692 |
| Intangibles | 0 | 0 | 16,248 | 17,509 | 18,770 |
| Other Non-Current Assets | 484 | 484 | 1,222 | 1,434 | 1,645 |
| TOTAL | $1,003 | $1,049 | $18,060 | $19,581 | $21,107 |
| Total Assets | $29,859 | $28,916 | $50,879 | $38,261 | $43,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 59 | 145 |
| Accounts payable and accrued liabilities | 5,394 | 1,944 | 2,682 | 2,806 | 3,662 |
| Accrued Expenses | 4,491 | 6,964 | 6,499 | 5,512 | 4,588 |
| Other current liabilities | N/A | 5,643 | 4,829 | 2,782 | N/A |
| TOTAL | $26,859 | $14,551 | $14,009 | $11,158 | $8,395 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 66,025 | 49,617 | 48,200 |
| Deferred Revenues | 16,974 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 22,759 | 0 | 50 | 0 | 4,058 |
| TOTAL | $22,913 | $25,835 | $66,371 | $49,929 | $52,587 |
| Total Liabilities | $49,772 | $40,386 | $80,381 | $61,087 | $60,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,490 | 10,100 | 10,517 | 8,201 | 8,201 |
| Common Shares | 844 | 844 | 657 | 658 | 658 |
| Retained earnings | -278,810 | -274,195 | -274,452 | -267,158 | -256,979 |
| Other shareholders' equity | 451 | 384 | 465 | 483 | 518 |
| TOTAL | $-19,914 | $-11,470 | $-29,501 | $-22,826 | $-17,224 |
| Total Liabilities And Equity | $29,859 | $28,916 | $50,879 | $38,261 | $43,757 |